aurobindo pharma's arm apl healthcare units get vai status from u.s. fda | halftime report
Published 1 year ago • 1.4K plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
1:39
aurobindo pharma gains in trade on back of positive note from brokerages | halftime report |cnbctv18
-
2:31
u.s. fda issues 10 observations to aurobindo pharma under form 483 | halftime report | cnbc-tv18
-
2:35
aurobindo pharma under pressure after us fda issues warning letter for eugia unit iii | cnbc tv18
-
8:09
aurobindo pharma's unit-iv plant gets clearance from us fda | midcap radar
-
2:05
u.s fda commences inspections of lupin and aurobindo pharma's facilities | halftime report
-
4:03
markets and ai can 'continue to roll on' without nvidia, says cic wealth's malcolm etheridge
-
6:19
big tech is your flight to safety and flight to growth, says constellation research's ray wang
-
4:26
pdd founder's wealth drops on cooling sales growth
-
3:24
aurobindo pharma under pressure after us fda issues 9 observations for eugia pharma's unit iii
-
3:41
aurobindo pharma likely to benefit from the us market: sanford bernstein's view on pharma sector
-
1:16
aurobindo pharma temporarily halts production at eugia’s unit-iii after 9 us fda observations
-
10:40
us business was impacted by seasonality in q1fy25: aurobindo pharma | cnbc tv18
-
2:10
aurobindo pharma's wholly-owned arm theranym inks biologics mfg deal with merck sharp & dohme
-
2:57
'buy' aurobindo pharma is today's trading idea by moneycontrol pro | halftime report
-
1:13
citi downgrades aurobindo pharma to sell; sees no material improvement in us generic dynamics
-
0:48
aurobindo pharma will consider a proposal for a buyback in its board meet on july 18 | cnbc tv18
-
12:23
key stocks in focus: siemens, jubilant foodworks, aurobindo pharma, honasa consumer, metro brands
-
1:55
aurobindo pharma gains in trade as it starts commercial production at 4 plants | cnbc tv18
-
7:48
see a lot of potential in the biologics space: aurobindo pharma | n18v | cnbc tv18
-
10:28
bino pathiparampil on indian pharma cos track record with the u.s fda | halftime report | cnbc-tv18
-
1:19
macquarie upgrades stocks of aurobindo pharma & ipca laboratories | bazaar open exchange
-
1:59
bofa & goldman sachs bullish on aurobindo pharma whereas clsa downgrades stock to outperform